Nanocomposites of gold nanoparticles with pregabalin: The future anti-seizure drug

Abstract

Application of nanoparticles in drug delivery has become an emerging phenomenon. This is typically achieved either via custom made nanoparticles or through the functionalization of pre-synthesized nanoparticles with the pharmaceutically active ingredients. In this study, Pregabalin, which is the active pharmaceutical ingredient of commercially available drug Lyrica, is used to functionalize pre-synthesized gold nanoparticles (AuNPs). The work was divided into two parts. The first part determined by synthesis of AuNPs. The second part was achieving conjugation of the AuNPs with Pregabalin to obtain nanocomposites (AuNPs-PGN). AuNPs formed were nanosized, spherical in shape, with a particle size ~35 nm. The probable nanocomposite formation takes place by conjugation between AuNPs and the carboxyl group (COOH) of Pregabalin.